Drug Shortage Report for NORMOSOL-R
Report ID | 160463 |
Drug Identification Number | 00039500 |
Brand name | NORMOSOL-R |
Common or Proper name | Multiple Electrolytes Injection Type 1 USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM GLUCONATE SODIUM ACETATE SODIUM CHLORIDE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE |
Strength(s) | 0.502G 0.222G 0.526G 0.014G 0.037G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000 mL |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-06-15 |
Actual start date | |
Estimated end date | 2022-07-29 |
Actual end date | 2022-07-29 |
Shortage status | Resolved |
Updated date | 2022-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-07-30 | English | Compare |
v8 | 2022-07-29 | French | Compare |
v7 | 2022-07-29 | English | Compare |
v6 | 2022-06-16 | English | Compare |
v5 | 2022-06-14 | French | Compare |
v4 | 2022-06-14 | English | Compare |
v3 | 2022-06-01 | English | Compare |
v2 | 2022-05-12 | French | Compare |
v1 | 2022-05-12 | English | Compare |
Showing 1 to 9 of 9